Furthermore, combining HER3 (461-471) epitope vaccination antibodies and peptide mimics with HER2 (266-296), HER2 (597-626), HER1 (418-435), and IGF-1R (56-81) vaccine antibodies and peptide mimics improved anticancer efficiency[145,146]
Furthermore, combining HER3 (461-471) epitope vaccination antibodies and peptide mimics with HER2 (266-296), HER2 (597-626), HER1 (418-435), and IGF-1R (56-81)…